SCHEMBL16015459

SCHEMBL16015459

C/C(=C\CC(O)C(=O)O)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 1/20 0.41
MTNR1B P49286 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
HSD17B10 Q99714 1/20 0.41
CES1 P23141 3/20 0.39
CES2 O00748 2/20 0.39
TSHR P16473 1/20 0.39
PTPRA P18433 1/20 0.38
DEGS1 O15121 1/20 0.37
ALDH1A1 P00352 1/20 0.37
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
CYP3A4 P08684 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
ALOX15 P16050 1/20 0.36
MAPK1 P28482 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4666803 0.82 MTNR1A (0.41) MTNR1AMTNR1BCYP1A2CYP2D6HSD17B10
SCHEMBL7254438 0.82 MTNR1A (0.41) MTNR1AMTNR1BCYP1A2CYP2D6HSD17B10
SCHEMBL4666793 0.82 MTNR1A (0.41) MTNR1AMTNR1BCYP1A2CYP2D6HSD17B10
SCHEMBL4666799 0.82 MTNR1A (0.41) MTNR1AMTNR1BCYP1A2CYP2D6HSD17B10
SCHEMBL10622948 0.79 LMNA (0.38) MTNR1AMTNR1BCYP1A2CYP2D6HSD17B10
SCHEMBL14837249 0.77 KDM1A (0.39) MTNR1AMTNR1BCYP1A2CYP2D6HSD17B10
SCHEMBL12512023 0.76 SMN1; SMN2 (0.45) MTNR1AMTNR1BCYP1A2CYP2D6HSD17B10
SCHEMBL1859897 0.74 HPGD (0.46) CYP1A2TSHRALDH1A1MEN1HPGD
SCHEMBL9723648 0.74 HTR2A (0.47)
SCHEMBL11313778 0.73 CYP1A2 (0.50) MTNR1AMTNR1BCYP1A2CYP2D6HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE45128-E1 Cephalotaxane derivatives and their processes of preparation and purification IVAX International GmbH (CH) 2014-09-09 US disclosed